Evidence map›Paper›PMID 30546215›Full record

ArticleJournal of conservative dentistry : JCD

Antibiofilm efficacy of biosynthesized silver nanoparticles against endodontic-periodontal pathogens: An

Kiran R Halkai, Rahul Halkai, Jayashree A Mudda, Vasundhara Shivanna, Vandana Rathod

Abstract read
In one paragraph

Article in Journal of conservative dentistry : JCD. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Review
  3. Journal of conservative dentistry and endodontics · 2024
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Molecules (Basel, Switzerland) · 2022
    Article
  10. Article
  11. Nanoparticles in Dentistry: A Comprehensive Review.Pharmaceuticals (Basel, Switzerland) · 2021
    Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kiran R HalkaiDepartment of Conservative Dentistry and Endodontics, HKE's SN Institute of Dental Sciences and Research, Kalaburgi, Karnataka, India.
Rahul HalkaiDepartment of Conservative Dentistry and Endodontics, College of Dentistry, Gulf Medical University, Ajman, United Arab Emirates.
Jayashree A MuddaDepartment of Periodontics, HKE's SN Institute of Dental Sciences and Research, Kalaburgi, Karnataka, India.
Vasundhara ShivannaDepartment of Conservative Dentistry and Endodontics, College of Dental Sciences, Davangere, Karnataka, India.
Vandana RathodDepartment of Microbiology, Gulbarga University, Kalaburgi, Karnataka, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEndodontic-periodontal pathogens exist as biofilms which are difficult to eliminate. Biosynthesized silver nanoparticles (AgNPs) emerged as newer antimicrobial agents with potential benefits.

aimThe aim of this study is to determine the minimum inhibitory concentration (MIC); evaluate the antibiofilm efficacy of fungal-derived AgNPs against MATERIALS AND

methodsMIC of AgNPs against test pathogens was determined using micro broth dilution method. Serial dilutions of AgNPs ranging from 80 to 1 μg/ml concentration were added to wells containing 10 μl of bacterial inoculum in culture media and control group without AgNPs. For biofilm models, 120 dentin blocks were prepared, sterilized, and contaminated for 2 weeks with (

resultsMIC for

conclusionFungal-derived AgNPs are effective against endo-perio pathogens.

Indexed as

Antimicrobial agentsbacterial resistancebiofilmbiosynthesized silver nanoparticlesendo-perio lesionsminimum inhibitory concentration

Identifiers

PMID30546215
PMCPMC6249955

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.